Distinctive CD39CD9 Lung Interstitial Macrophages Suppress IL-23/Th17-mediated Neutrophilic Asthma by Inhibiting NETosis
Overview
Authors
Affiliations
The IL-23-Th17 axis is responsible for neutrophilic inflammation in various inflammatory diseases. Here, we discover a potential pathway to inhibit neutrophilic asthma. In our neutrophil-dominant asthma (NDA) model, single-cell RNA-seq analysis identifies a subpopulation of CD39CD9 interstitial macrophages (IMs) suppressed by IL-23 in NDA conditions but increased by an IL-23 inhibitor αIL-23p19. Adoptively transferred CD39CD9 IMs suppress neutrophil extracellular trap formation (NETosis), a representative phenotype of NDA, and also Th17 cell activation and neutrophilic inflammation. CD39CD9 IMs first attach to neutrophils in a CD9-dependent manner, and then remove ATP near neutrophils that contribute to NETosis in a CD39-dependent manner. Transcriptomic data from asthmatic patients finally show decreased CD39CD9 IMs in severe asthma than mild/moderate asthma. Our results suggest that CD39CD9 IMs function as a potent negative regulator of neutrophilic inflammation by suppressing NETosis in the IL-23-Th17 axis and can thus serve as a potential therapeutic target for IL-23-Th17-mediated neutrophilic asthma.
Chronic Inflammation in Asthma: Looking Beyond the Th2 Cell.
Olsthoorn S, van Krimpen A, Hendriks R, Stadhouders R Immunol Rev. 2025; 330(1):e70010.
PMID: 40016948 PMC: 11868696. DOI: 10.1111/imr.70010.
The Importance of Lung Innate Immunity During Health and Disease.
Ryanto G, Suraya R, Nagano T Pathogens. 2025; 14(1).
PMID: 39861052 PMC: 11768135. DOI: 10.3390/pathogens14010091.